Christopher Russell Kannady

Christopher Kannady practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Christopher Kannady's NPI, 1780001966, was assigned on March 25, 2014. Christopher Kannady graduated from LSU Health Shreveport School of Medicine in 2014. Christopher Kannady holds Texas license R9506.

Christopher Kannady's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Christopher Kannady's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Christopher Kannady is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is CLS Health. Dmand AI also links Christopher Kannady to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Kannady practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Christopher Kannady's primary specialty in the NPI Registry, under taxonomy code 208800000X. Christopher Kannady is board certified in urology by the American Board of Urology. Christopher Kannady is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and testicular dysfunction among the conditions Christopher Kannady treats.

CMS data shows 422 Medicare services from Christopher Kannady across 12 procedure codes in 2024, for 85 Medicare patients. Medicare paid $27,187 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Christopher Kannady in 2024. The largest group is 65 to 74, with 54 patients. 71% of them have high blood pressure, and 65% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Kannady's median patient age at 53, with 14% women.

In 2024, Christopher Kannady wrote 741 Medicare Part D claims for 223 patients. 82% of them were for generic drugs. CMS names the drug for 631 of them, across 16 drugs with 11 or more claims each, at $80,304 in total drug cost. In 2023, CMS named 1,262 claims across 15 drugs.

Christopher Kannady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Kannady as offering telehealth.

Dmand AI links 5 papers to Christopher Kannady, published from 2020 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Erectile Dysfunction, Penile Implantation and Penile Prosthesis. Christopher Kannady's most frequent co-authors are Run Wang, MD, Travis Paul Green, MD and Sravan Panuganti, DO.

CMS Open Payments shows 212 general payments to Christopher Kannady from 47 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 64% of the total. Endo Pharmaceuticals Inc. paid the most, $3,332.

Christopher Kannady graduated from LSU Health Shreveport School of Medicine in 2014.

Christopher Kannady is in network with 21 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.